Cargando…
Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212428/ http://dx.doi.org/10.1016/S0016-5085(22)63686-2 |
_version_ | 1784730589957455872 |
---|---|
author | Kalligeros, Markos Shehadeh, Fadi Kothadia, Savan Marino, Daniel Mylona, Evangelia Wands, Jack R. Mylonakis, Eleftherios |
author_facet | Kalligeros, Markos Shehadeh, Fadi Kothadia, Savan Marino, Daniel Mylona, Evangelia Wands, Jack R. Mylonakis, Eleftherios |
author_sort | Kalligeros, Markos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9212428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AGA Institute. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92124282022-06-22 Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB Kalligeros, Markos Shehadeh, Fadi Kothadia, Savan Marino, Daniel Mylona, Evangelia Wands, Jack R. Mylonakis, Eleftherios Gastroenterology AASLD Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212428/ http://dx.doi.org/10.1016/S0016-5085(22)63686-2 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | AASLD Abstracts Kalligeros, Markos Shehadeh, Fadi Kothadia, Savan Marino, Daniel Mylona, Evangelia Wands, Jack R. Mylonakis, Eleftherios Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title | Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title_full | Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title_fullStr | Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title_full_unstemmed | Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title_short | Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB |
title_sort | tu1265: liver injury in hospitalized covid-19 patients treated with tocilizumab |
topic | AASLD Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212428/ http://dx.doi.org/10.1016/S0016-5085(22)63686-2 |
work_keys_str_mv | AT kalligerosmarkos tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT shehadehfadi tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT kothadiasavan tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT marinodaniel tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT mylonaevangelia tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT wandsjackr tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab AT mylonakiseleftherios tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab |